<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr107-0300060519845488">
 <label>107</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Smith</surname>
    <given-names>GE</given-names>
   </name>
   <name>
    <surname>Flyer</surname>
    <given-names>DC</given-names>
   </name>
   <name>
    <surname>Raghunandan</surname>
    <given-names>R</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.</article-title>
  <source>Vaccine</source>
  <year>2013</year>; 
  <volume>31</volume>: 
  <fpage>4305</fpage>–
  <lpage>4313</lpage>. 2013/07/31. DOI: 10.1016/j.vaccine.2013.07.043.
  <pub-id pub-id-type="pmid">23891795</pub-id>
 </mixed-citation>
</ref>
